Navigation Links
Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results
Date:8/13/2009

et of tax, net income attributable to Shamir's shareholders for the quarter was $4.3 million, or $0.26 per diluted share, compared with net income of $3.2 million, or $0.19 per diluted share for the same period last year.

The reconciliation of GAAP operating income and GAAP net income to non-GAAP operating income and non-GAAP net income is set forth below.

As of June 30, 2009, the Company had cash and cash equivalents, including short-term investments of $27.4 million.

Commenting on the results, Amos Netzer, Chief Executive Officer of Shamir, said, "During the past few years, Shamir has worked diligently, not only to expand our geographic footprint, but also to improve our manufacturing capabilities and solidify and expand our sales and marketing capabilities. The positive effect of these efforts is reflected in our favorable results for the second quarter. In Europe, we generated improved sales and operating results and our operations in the United States continued to perform well."

Mr. Netzer added, "To support our long range goals of expanding our selling and manufacturing capabilities, in July 2009 we increased our ownership in our lab in Thailand from 40.4% to 51%. We are very encouraged with the performance of our investment in Thailand and are pleased to have been able to increase our ownership in the subsidiary."

Mr. Netzer concluded, "In terms of our overall strategy, we continue to maintain a strong balance between investing in long-term growth and monitoring operational expenses, which helped us achieve positive performance thus far this year. However, due to the uncertainty in the global economic landscape and the remaining challenges, our visibility for the second half of 2009 is unclear."

Conference Call:

Shamir has scheduled a conference call for 11:00 a.m. today to discuss second quarter results. To participate
'/>"/>

SOURCE Shamir Optical Industry Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter of 2009 Earnings Results
2. Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Failure to Satisfy Continued Listing Requirements
3. Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter of 2009 Earnings Results
4. Shamir Optical Industry Ltd. Appoints Amos Netzer as New Chief Executive Officer
5. Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Noncompliance with Nasdaq Audit Committee Composition Requirements
6. Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results
7. Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2008 Earnings Results
8. Shamir Optical Industry Ltd. Reports Third Quarter 2008 Results
9. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter 2008 Earnings Results
10. Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH
11. Shamir Optical Industry Ltd. Reports First Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... were treated with cisplatin-based chemotherapy ha... side effects and Raynaud-like phenomena, than men... to a new study published online November 25 in th...Marianne Brydy, M.D., of the Department of Oncolog...y, and colleagues conducted a cross-sectional stud...
(Date:11/25/2009)...aw definite conclusions, experts say, , ...tic patients with blocked coronary arteries, there...ar whether patients undergo bypass surgery or angi... , Bypass surgery has been the standard treatme...ase. However, less invasive approaches such as ang...
(Date:11/25/2009)...ms, study finds , , WEDNESDAY, Nov. 25 ...among the potential problems faced by long-term su... cisplatin-based chemotherapy, a new study has fou...eated for unilateral testicular cancer between 198...ducted from 1998 to 2002. , The researchers fou...
(Date:11/25/2009)...ghtYear ,, WASHINGTON,Nov.25/PRNewswire-USNew...issuedthe 4thAnnualReportCardonLungCancer .ThisRep...haldiseaseinthestateofGeorgia.LCA-GAisachapterofLu...edicatedexclusivelytopatientsupportandadvocacyforp... http://www.newscom.com/cgi-bin/prnh/20081016/LCAL...
(Date:11/25/2009)...r cells, study finds , , WEDNESDAY, Nov.... in a fingernail-size implant eliminated melanoma ...od uses polymer disks, 8.5 millimeters in diameter... implanted under the skin to reprogram the immune ...ientists who developed the implant predicted that ...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
... Tips on When to Bring Pet...la. (Vocus) January 6, 2009 -- Whether you commit...ans are urging you to commit to your pets this yea...,s life saved and less costly medical bills for pe...
... Researchers at North Carolina State University an...ave produced the first link between a species of b...ness. , Dr. Edward Breitschwerdt, professor of in...rom samples of human blood. , B. melophagi is s...
... The University of California, San Francisco has r...da Gates Foundation to address the shortage of hea...ll support a strategic collaboration between UCSF ...ble MUHAS and other African institutions to meet t...
...Center to Host Web-Based Community for Parents of .... 6 ChildRC.com, an online support community for ...launch of The Child Resource Center. Designed to a... www.ChildRC.com ) offers informative content and ...
...ACQUIRES HEMATOLOGY BUSINESS ASSETS FROM BIOCODE H...rp. (Nasdaq Capital Market: ESMC) announced that o...Agreement it completed the previously announced ac...ts. The acquired hematology business will continue...
...nding means condition could be biologically driven...lthDay News) -- Children who are traumatized by se...ely to develop chronic fatigue syndrome as adults,...re appears to be a connection between the nervous ...
Other Medicine News:Health News:Early Detection Saves Pets 2Health News:Early Detection Saves Pets 3Health News:NC State researchers find new bartonella species that infects humans 2Health News:UCSF-Tanzania get $7.5M from Gates Foundation for partnership to train African health workers 2Health News:ChildRC.com Launches The Child Resource Center 2Health News:Escalon(R) Medical Corp. Completes Bolt-On Acquisition, Enhances Market Position in France and Expands Product Offering 2Health News:Escalon(R) Medical Corp. Completes Bolt-On Acquisition, Enhances Market Position in France and Expands Product Offering 3Health News:Childhood Trauma Tied to Chronic Fatigue Syndrome 2Health News:Childhood Trauma Tied to Chronic Fatigue Syndrome 3
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, IntranasalDrugDelivery-USMarketTrend...67/Intranasal-Drug-Delivery---US-Market-Trends--An...etiswitnessinganexpansionoftherapeuticapplications...tothedeliveryofsystemictherapeuticdrugs.Thefutureo...
(Date:11/24/2009)...ETHESDA,Md.,Nov.24/PRNewswire-Asia/--ChindexIntern...dependentAmericanproviderofWestern,healthcareprodu...nnouncedthattheCompanywillattendthe21stAnnualPiper...cember1-2,2009,atthe,NewYorkPalaceHotel. , Ma...Tuesday,December1,2009,andholdone-on-onemeetingst...
(Date:11/24/2009)...REMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermil...nyfileditsPlanofReorganizationandDisclosureStateme...tcyCourtfortheDistrictofDelaware.Ahearingtoconside...ledforDecember8,2009,withthehearingontheconfirmati...ncallsfortheCompanytopayallclaimsinfull.ThePlanise...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Thomson Reuters Offers Average Wholesale Pricing Information for Workers Compensation Drug Claims 48375 1Thomson Reuters Offers Average Wholesale Pricing Information for Workers Compensation Drug Claims 48375 2Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 1Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 2Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 1Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 2Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 3Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 4Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 5Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 6Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 7Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 8Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 9Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 10Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 11
... -FIXED DOSE COMBINATION WITH DIURETIC ACCEPTED FO...TER, NJ, 21 May 2007 -,Speedel (SWX: SPPN) today ... trials of SPP100 (aliskiren, Tekturna/Rasliez[1])...entific Meeting,and Exposition of the American Soc...ese results confirm the favourable safety and,effi...
... ANAHEIM, Calif., May 19, 2007 /PRNewswire/ -- Dat... that Levaquin (levofloxacin),750 mg tablets admin...s standard therapy of ciprofloxacin (400/500 mg) f...y tract infections,(cUTI) and acute pyelonephritis...ets LEVAQUIN in the,U.S., presented the data durin...
Other Medicine Technology:New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 2New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 3New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 4New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 5New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 7New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 9New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 10New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 11Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 2Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 3Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 4
Atakr II RF Ablation System
...X Single Plane Imaging System is the Fischer answe...he electrophysiology specialist. The EP-X system i...ed and dedicated EP lab system. Ease of access to ... Progressive Fluoroscopy (PPF) are but a few of th...
...ogy software increases your office efficiency by r...y utilizing a comprehensive cardiology software so...pects of your practice and more time on your patie...ete practice solution. With over 50,000 installati...
...ys solution, called PrimeSuite, is a Web Browser-b...rated Practice Management, Electronic Medical Reco...et the healthcare industrys demand for dependable ...of a suite of physician-centric software products ...
Medicine Products: